Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01370239 | HumanaH - Hu3s193 in the Treatment of Advanced Breast Cancer After Hormonal Therapy | terminated | Phase 2 | 23 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Oct 11, 2019 | clinicaltrials |
| NCT02950480 | Breast Capsular Contracture Following Post-Mastectomy Reconstruction in Women Treated With the Leukotriene Inhibitor Zafirlukast: A Phase II Trial | terminated | Phase 2 | 4 | University of California, San FranciscoOTHER | 1 | Oct 1, 2019 |
| clinicaltrials |
| NCT02582801 | Clinical Research of 18F-Alfatide Ⅱ PET/CT in Breast Cancer | terminated | Phase 1 | 46 | Jiang WuOTHER | 1 | Sep 27, 2019 | clinicaltrials |
| NCT03456661 | Comparison Between Levobupivacaine and Levobupivacaine With Dexmedetomidine in Ultrasound Guided Pectoral Nerve Block | terminated | Phase 4 | 40 | University Hospital, AntwerpOTHER | 1 | Sep 20, 2019 | clinicaltrials |
| NCT00972023 | DHEA in Treating Women Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer | terminated | Phase 1 | 1 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Sep 17, 2019 | clinicaltrials |
| NCT01891357 | Phase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Breast Cancer | terminated | Phase 2 | 64 | Women's Cancer Study Group GmbHOTHER | 1 | Sep 17, 2019 | clinicaltrials |
| NCT03417024 | Automated Breast Ultrasound Case Collection Registry | terminated | — | 13 | GE HealthcareINDUSTRY | 1 | Sep 9, 2019 | clinicaltrials |
| NCT02054338 | A Study of Vinflunine Plus Gemcitabine Versus Paclitaxel Plus Gemcitabine in Patients With Advanced Breast Cancer(VICTORIA) | terminated | Phase 3 | 1,004 | Pierre Fabre MedicamentINDUSTRY | 0 | Aug 28, 2019 | clinicaltrials |
| NCT02598310 | Neoadjuvant Nab-PTX and Trastuzumab for ER Negative and HER2 Positive Breast Cancer | terminated | Phase 2 | 30 | Osaka Medical CollegeOTHER | 1 | Aug 28, 2019 | clinicaltrials |
| NCT03557554 | Investigating the Preventative Ability of Massage Therapy on Paclitaxel Induced Peripheral Neuropathy(PIPN) | terminated | N/A | 5 | Bryan SchneiderOTHER | 1 | Aug 26, 2019 | clinicaltrials |
| NCT01243541 | Cryotherapy in Preventing Peripheral Neuropathy and Nail Toxicity in Patients With Breast Cancer Who Are Receiving Paclitaxel | terminated | N/A | 33 | Northwestern UniversityOTHER | 1 | Aug 20, 2019 | clinicaltrials |
| NCT01506700 | Real Time Optical Coherence Tomography (OCT) of Human Tissue | terminated | — | 5 | Diagnostic Photonics, Inc.INDUSTRY | 1 | Jul 26, 2019 | clinicaltrials |
| NCT03197805 | Assessment of the Impact of RNA Genomic Profile on Treatment Decision-making in HER2 Equivocal Breast Cancer Patients(EQUIVOK) | terminated | N/A | 26 | Centre Jean PerrinOTHER | 1 | Jul 25, 2019 | clinicaltrials |
| NCT03318562 | A PD Study of Oral eFT508 in Subjects With Advanced TNBC and HCC | terminated | Phase 2 | 3 | Effector TherapeuticsINDUSTRY | 1 | Jul 18, 2019 | clinicaltrials |
| NCT02389764 | Nintedanib For HER2-Negative Metastatic Inflammatory Breast Cancer (MIBC) | terminated | Phase 2 | 10 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 17, 2019 | clinicaltrials |
| NCT03062007 | Open-label Study of Safety, Tolerability and Pharmacokinetics of Multiple Doses of BI-CON-02 in Patients With HER2-positive Metastatic Breast Cancer, Previously Treated With Trastuzumab | terminated | Phase 1 | 6 | Biointegrator LLCINDUSTRY | 1 | Jul 16, 2019 | clinicaltrials |
| NCT01138553 | Preoperative Testing of the Anti-Progesterone Mifepristone in Early Stage Breast Cancer | terminated | Early Phase 1 | 4 | University of California, San DiegoOTHER | 1 | Jul 8, 2019 | clinicaltrials |
| NCT00759642 | Lapatinib in Women With Metastatic Breast Cancer Who Have Failed Prior Antihormone Therapy | terminated | Phase 2 | 33 | University of Kansas Medical CenterOTHER | 1 | Jul 1, 2019 | clinicaltrials |
| NCT00885183 | Adjuvant Acupuncture Care for Breast Cancer Patients Experiencing Side Effects From Chemotherapy(Acubreast) | terminated | N/A | 10 | University Hospital of North NorwayOTHER | 1 | Jul 1, 2019 | clinicaltrials |
| NCT02005614 | A Pilot/Phase II Study of Gamma Knife Radiosurgery for Brain Metastases Using 3Tesla MRI and Rational Dose Selection | terminated | N/A | 39 | Yale UniversityOTHER | 1 | Jul 1, 2019 | clinicaltrials |
| NCT01159067 | Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload | terminated | Phase 2 | 1 | City of Hope Medical CenterOTHER | 1 | Jun 18, 2019 | clinicaltrials |
| NCT02153905 | T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-A*01 Positive | terminated | Phase 1 / Phase 2 | 3 | National Cancer Institute (NCI)NIH | 1 | Jun 17, 2019 | clinicaltrials |
| NCT00784524 | Phase II Study of Allo LMI Vaccine With IL-2 for Stable Metastatic Breast Ca | terminated | Phase 2 | 14 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Jun 6, 2019 | clinicaltrials |
| NCT02012608 | Glutamine for the Prevention of Radiation Toxicity in Subjects Conserving Therapy | terminated | Phase 2 | 14 | University of ArkansasOTHER | 1 | May 29, 2019 | clinicaltrials |
| NCT02674204 | STOP Heart Disease in Breast Cancer Survivors Trial(STOP) | terminated | Phase 2 | 2 | Cedars-Sinai Medical CenterOTHER | 1 | May 15, 2019 | clinicaltrials |
| NCT02566109 | Community Hospital Identification of High CV Risk Patients During Cancer Treatment(CHI) | terminated | N/A | 6 | Wake Forest University Health SciencesOTHER | 1 | May 8, 2019 | clinicaltrials |
| NCT02136927 | Bioavailability Study of SPARC1210 and Reference1210 in Subjects With Metastatic Breast Cancer | terminated | Phase 1 | 33 | Sun Pharma Advanced Research Company LimitedINDUSTRY | 1 | May 3, 2019 | clinicaltrials |
| NCT02777164 | Evaluation of a 3D Functional Metabolic Imaging and Risk Assessment System for Classifying Women at High Risk of Breast Cancer | terminated | N/A | 740 | Real Imaging Ltd.INDUSTRY | 1 | May 3, 2019 | clinicaltrials |
| NCT03288792 | A Evaluation of 3D Functional MIRA System in Women With Mammographically Dense Breasts | terminated | N/A | 435 | Real Imaging Ltd.INDUSTRY | 1 | May 3, 2019 | clinicaltrials |
| NCT00503841 | Erlotinib in Treating Women Undergoing Surgery For Stage I, Stage II, or Stage III Breast Cancer | terminated | N/A | 44 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 30, 2019 | clinicaltrials |
| NCT02078752 | A Study Of PF-06647263 In Patients With Advanced Solid Tumors | terminated | Phase 1 | 60 | PfizerINDUSTRY | 1 | Apr 29, 2019 | clinicaltrials |
| NCT02384746 | Phase I Study of the Combination of MLN9708 and Fulvestrant(Millennium) | terminated | Phase 1 | 9 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Apr 29, 2019 | clinicaltrials |
| NCT00695968 | Breast Density and the Role of Preoperative Mammography, Ultrasound, Elastography and MRI | terminated | — | 9 | Stanford UniversityOTHER | 1 | Apr 18, 2019 | clinicaltrials |
| NCT02658084 | Vinorelbine With Trastuzumab Emtansine in Pre-Treated HER2-Positive Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 2 | University of MiamiOTHER | 1 | Apr 17, 2019 | clinicaltrials |
| NCT00130494 | Zoledronic Acid Administration to Metastatic Breast Cancer Patients With Non-symptomatic Bone Lesions | terminated | Phase 3 | 97 | Spanish Breast Cancer Research GroupOTHER | 1 | Apr 16, 2019 | clinicaltrials |
| NCT02872363 | Does the Wording of Text Message Reminders Improve Uptake in Breast Screening? | terminated | N/A | 7,944 | Imperial College Healthcare NHS TrustOTHER | 1 | Apr 11, 2019 | clinicaltrials |
| NCT01303419 | Contrast-Enhanced Digital Mammography (CEDM) for Identifying a Change in Management of Women With Newly Diagnosed Breast Cancer | terminated | N/A | 224 | GE HealthcareINDUSTRY | 5 | Apr 10, 2019 | clinicaltrials |
| NCT00462865 | Trial of Chemotherapy and Avastin as Treatment for Women With Breast Cancer at High Risk for Relapse | terminated | Phase 2 | 18 | Brown UniversityOTHER | 1 | Apr 9, 2019 | clinicaltrials |
| NCT02129205 | A Dose Escalation Study of PF-06650808 in Patients With Advanced Solid Tumors | terminated | Phase 1 | 40 | PfizerINDUSTRY | 1 | Mar 29, 2019 | clinicaltrials |
| NCT02923037 | Hatha Yoga in Breast Cancer Survivors | terminated | N/A | 27 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Mar 26, 2019 | clinicaltrials |
| NCT00080626 | Neoadjuvant Docetaxel in Treating Women With Newly Diagnosed Breast Cancer | terminated | Phase 2 | 19 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Mar 21, 2019 | clinicaltrials |
| NCT01445054 | 111 Indium CHX-A DTPA Trastuzumab (Indium-Herceptin) for Imaging Breast Cancer | terminated | Early Phase 1 | 13 | National Cancer Institute (NCI)NIH | 1 | Mar 11, 2019 | clinicaltrials |
| NCT00063934 | Oblimersen Plus Doxorubicin and Docetaxel in Treating Patients With Metastatic or Locally Advanced Breast Cancer | terminated | Phase 1 / Phase 2 | 31 | National Cancer Institute (NCI)NIH | 1 | Mar 5, 2019 | clinicaltrials |
| NCT00130507 | Benefit of Adding Trastuzumab to Second Line Chemotherapy in Breast Cancer Patients Previously Treated With Trastuzumab | terminated | Phase 2 | 14 | Spanish Breast Cancer Research GroupOTHER | 1 | Feb 26, 2019 | clinicaltrials |
| NCT02324205 | Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthesis Compared to Mammography (ADAPT)(ADAPT) | terminated | N/A | 196 | GE HealthcareINDUSTRY | 2 | Feb 26, 2019 | clinicaltrials |
| NCT02883790 | Effects of Somnage® in the Management on Sleep and Mood in Cancer Patients | terminated | N/A | 3 | Helsinn Healthcare SAINDUSTRY | 1 | Feb 22, 2019 | clinicaltrials |
| NCT00434941 | Capecitabine Plus Radiotherapy for Local Relapse Breast Cancer With Negative Her2 Tumours | terminated | Phase 2 | 1 | Spanish Breast Cancer Research GroupOTHER | 1 | Feb 21, 2019 | clinicaltrials |
| NCT02540083 | Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthesis Compared to Mammography(ADAPT-ENRICH) | terminated | N/A | 94 | GE HealthcareINDUSTRY | 1 | Feb 5, 2019 | clinicaltrials |
Data updated 23 days agoSource updated Oct 11, 2019source: clinicaltrials